The study found that NSCLC patients had a higher prevalence of all tested TLRs (TLR2, TLR3, TLR4, TLR7, TLR8, TLR9) in peripheral blood lymphocyte subpopulations compared to healthy volunteers. This evidence concerns the gene TLR3 and non-small cell lung carcinoma.